{"name":"Berinstein, Jeffrey","slug":"berinstein-jeffrey","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Cyclosporine Injection (IV)","genericName":"Cyclosporine Injection (IV)","slug":"cyclosporine-injection-iv","indication":"Prevention of organ rejection in transplant recipients (kidney, heart, liver, pancreas)","status":"marketed"},{"name":"Oral Prednisone - Hospital Dose Steroids","genericName":"Oral Prednisone - Hospital Dose Steroids","slug":"oral-prednisone-hospital-dose-steroids","indication":"Acute inflammatory conditions requiring high-dose corticosteroid therapy","status":"marketed"},{"name":"Prednisone Oral Product","genericName":"Prednisone Oral Product","slug":"prednisone-oral-product","indication":"Rheumatoid arthritis","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Intravenous Methylprednisolone","genericName":"Intravenous Methylprednisolone","slug":"intravenous-methylprednisolone","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Oral prednisolone Taper","genericName":"Oral prednisolone Taper","slug":"oral-prednisolone-taper","indication":"Inflammatory and autoimmune conditions (e.g., rheumatoid arthritis, lupus, vasculitis)","status":"marketed"}]}],"pipeline":[{"name":"Cyclosporine Injection (IV)","genericName":"Cyclosporine Injection (IV)","slug":"cyclosporine-injection-iv","phase":"marketed","mechanism":"Cyclosporine is a calcineurin inhibitor that suppresses T-cell activation by blocking the transcription of pro-inflammatory cytokines.","indications":["Prevention of organ rejection in transplant recipients (kidney, heart, liver, pancreas)","Severe rheumatoid arthritis","Severe psoriasis","Nephrotic syndrome","Autoimmune uveitis"],"catalyst":""},{"name":"Intravenous Methylprednisolone","genericName":"Intravenous Methylprednisolone","slug":"intravenous-methylprednisolone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oral Prednisone - Hospital Dose Steroids","genericName":"Oral Prednisone - Hospital Dose Steroids","slug":"oral-prednisone-hospital-dose-steroids","phase":"marketed","mechanism":"Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Acute inflammatory conditions requiring high-dose corticosteroid therapy","Autoimmune disorders (e.g., lupus, vasculitis)","Severe allergic reactions","Acute exacerbations of chronic inflammatory diseases","Organ transplant rejection prophylaxis"],"catalyst":""},{"name":"Oral prednisolone Taper","genericName":"Oral prednisolone Taper","slug":"oral-prednisolone-taper","phase":"marketed","mechanism":"Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Inflammatory and autoimmune conditions (e.g., rheumatoid arthritis, lupus, vasculitis)","Allergic reactions and asthma exacerbations","Adrenal insufficiency","Certain hematologic and oncologic conditions"],"catalyst":""},{"name":"Prednisone Oral Product","genericName":"Prednisone Oral Product","slug":"prednisone-oral-product","phase":"marketed","mechanism":"Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in cells.","indications":["Rheumatoid arthritis","Systemic lupus erythematosus","Polymyalgia rheumatica","Giant cell arteritis","Asthma"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":5,"phaseCounts":{"marketed":5},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}